Cargando…

P16-49. Broad types of cytokines secreted by Gag-specific T cells from HIV infected patients on HAART

Detalles Bibliográficos
Autores principales:	Montes, M, Loof, N, Cobb, A, Jutras, D, Quinn, C, Plants, J, Zurawski, S, King, B, Sloan, L, Levy, Y, Banchereau, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767779/ http://dx.doi.org/10.1186/1742-4690-6-S3-P278

Ejemplares similares

P16-29. HIV Nef-specific T cells: Th1/CTL, Th2 and Th17 responses
por: Montes, M, et al.
Publicado: (2009)

S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies
por: Loof, N, et al.
Publicado: (2009)

P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
por: Flamar, A, et al.
Publicado: (2009)

Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients
por: Levy, Y, et al.
Publicado: (2012)

Targeting HIV Gag p24 to DICR on dendritic cells induces T cell and potent and long-lasting antibody responses in non-human primates
por: Flamar, A, et al.
Publicado: (2012)

P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine
por: Martinon, F, et al.
Publicado: (2009)

Immune response after vaccination of HIV infected individuals receiving HAART with overlapping gag peptides pulsed on autologous cells
por: Kløverpris, H, et al.
Publicado: (2012)

P19-45. Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens
por: Cobb, AJ, et al.
Publicado: (2009)

Immunodominant Anti-Gag SLYNTVATL Responses in HIV-patients With More Than Five Years of HAART-induced Undetectable Plasma Viremia
por: Remenar, Anica, et al.
Publicado: (2005)

Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo
por: Flamar, Anne-Laure, et al.
Publicado: (2015)

P17-16. Anti-Langerin-HIV Gag p24 fusion protein targeting Langerhans cells as a new anti-HIV vaccine strategy
por: Culina, S, et al.
Publicado: (2009)

P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial
por: Banchereau, J, et al.
Publicado: (2009)

New insights into retroviral Gag–Gag and Gag–membrane interactions
por: Maldonado, José O., et al.
Publicado: (2014)

Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads
por: Rolland, Morgane, et al.
Publicado: (2008)

Nephrotoxicity of HAART
por: Kalyesubula, Robert, et al.
Publicado: (2011)

A first-in-man, double blind, placebo controlled study of the candidate therapeutic vaccine Opal-HIV-Gag(c) in HIV infected patients receiving HAART
por: Jackson, AG, et al.
Publicado: (2012)

Gag-Gag Interactions Are Insufficient to Fully Stabilize and Order the Immature HIV Gag Lattice
por: Saha, Ipsita, et al.
Publicado: (2021)

Neurodegeneration in the HAART era
por: Brew, Bruce J
Publicado: (2010)

Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen
por: Ondondo, Beatrice, et al.
Publicado: (2006)

Gag and Stroke
por: Smithard, David
Publicado: (1994)

FRET analysis of HIV‐1 Gag and GagPol interactions
por: Takagi, Shimon, et al.
Publicado: (2017)

HIV and HAART-Associated Dyslipidemia
por: Feeney, Eoin R, et al.
Publicado: (2011)

HAART and the liver: friend or foe?
por: Pineda, JA, et al.
Publicado: (2010)

HAART, THE HEART AND THE POTENTIAL FOR INTERACTION
por: Coyle, Liam, et al.
Publicado: (2022)

Oral lesions among HIV seropositive individuals in an era of generic HAART: markers of HAART efficacy?
por: Vasudevan, Janani, et al.
Publicado: (2012)

SUN-168 HAART-Induced Hyperglycemic Hyperosmolar Syndrome: A Rare Manifestation of HAART Therapy
por: Vora, Aarohi, et al.
Publicado: (2019)

Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells
por: Melssen, Marit M, et al.
Publicado: (2015)

Gauging Gag assembly
por: Short, Ben
Publicado: (2015)

31. Gagging and prosthodontics
por: Ashish, T, et al.
Publicado: (2018)

Modulation of HIV-1 Gag/Gag-Pol frameshifting by tRNA abundance
por: Korniy, Natalia, et al.
Publicado: (2019)

Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package
por: Lin, Yi-Ru, et al.
Publicado: (2022)

P16-16. Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda
por: Kyosiimire-Lugemwa, J, et al.
Publicado: (2009)

HIV/HAART and the brain — what's going on?
por: Portegies, P
Publicado: (2010)

Premature and accelerated aging: HIV or HAART?
por: Smith, Reuben L., et al.
Publicado: (2013)

Plasma Membrane Anchoring and Gag:Gag Multimerization on Viral RNA Are Critical Properties of HIV-1 Gag Required To Mediate Efficient Genome Packaging
por: Duchon, Alice, et al.
Publicado: (2021)

High level of adherence to HAART among refugees and internally displaced persons on HAART in western equatorial region of Southern Sudan
por: Salami, O, et al.
Publicado: (2010)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
por: Sinha, Rajesh, et al.
Publicado: (2008)

Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study
por: Fekene, Tamirat Edie, et al.
Publicado: (2018)

Autobiography of a gag-writer
por: Alexander, Dick
Publicado: (1961)

Determinants of Glycosaminoglycan (GAG) Structure
por: Prydz, Kristian
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1hv6li9tpsei5mrb8173ulcg5v